Value of quantitative sensory testing in neurological and pain disorders: NeuPSIG consensus

被引:450
作者
Backonja, Miroslav 'Misha'' [1 ]
Attal, Nadine [2 ,3 ]
Baron, Ralf [5 ]
Bouhassira, Didier [3 ,4 ]
Drangholt, Mark [6 ]
Dyck, Peter J. [7 ]
Edwards, Robert R. [8 ]
Freeman, Roy [9 ]
Gracely, Richard [10 ]
Haanpaa, Maija H. [11 ]
Hansson, Per [12 ]
Hatem, Samar M. [13 ,14 ,15 ]
Krumova, Elena K. [16 ]
Jensen, Troels S. [17 ,18 ]
Maier, Christoph [19 ]
Mick, Gerard [20 ]
Rice, Andrew S. [21 ,22 ]
Rolke, Roman [23 ]
Treede, Rolf-Detlef [24 ,25 ,26 ]
Serra, Jordi [27 ]
Toelle, Thomas [28 ]
Tugnoli, Valeri [29 ]
Walk, David [3 ,30 ]
Walalce, Mark S. [31 ]
Ware, Mark [32 ,33 ]
Yarnitsky, David [34 ]
Ziegler, Dan [35 ,36 ,37 ]
机构
[1] Univ Wisconsin, Dept Neurol, Madison, WI 53706 USA
[2] CRI Lifetree Res, Salt Lake City, UT USA
[3] AP HP, Hop Ambroise Pare, Ctr Evaluat & Traitement Douleur, INSERM U 987, Boulogne, France
[4] Univ Versailles, St Quentin en Yvelines, France
[5] Univ Klinikum Schleswig Holstein, Dept Neurol, Div Neurol Pain Res & Therapy, Kiel, Germany
[6] Univ Washington, Dent Publ Hlth Sci, Seattle, WA 98195 USA
[7] Mayo Clin, Rochester, MN USA
[8] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Anesthesiol, Chestnut Hill, MA USA
[9] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Neurol, Boston, MA 02215 USA
[10] Univ N Carolina, Ctr Neurosensory Disorders, Chapel Hill, NC USA
[11] Univ Helsinki, Cent Hosp, Dept Neurosurg, Helsinki, Finland
[12] Karolinska Inst, Dept Mol Med & Surg, Clin Pain Res, S-17176 Stockholm, Sweden
[13] Brugmann Univ Hosp, Clin Phys & Rehabil Med, B-1020 Brussels, Belgium
[14] Inst Neurosci, B-1200 Brussels, Belgium
[15] Catholic Univ Louvain, B-3000 Louvain, Belgium
[16] Ruhr Univ Bochum, Berufsgenossenschaftl Univ Klinkum Bergmannsheil, Dept Neurol, Bochum, Germany
[17] Aarhus Univ Hosp, Danish Pain Res Ctr, DK-8000 Aarhus, Denmark
[18] Aarhus Univ Hosp, Dept Neurol, DK-8000 Aarhus, Denmark
[19] Ruhr Univ Bochum, Berufsgenossenschaftl Univ Klinikum Bergmansheil, Dept Pain Med, Bochum, Germany
[20] Univ Neurol Hosp, Ctr Pain Evaluat & Treatment, Lyon, France
[21] Imperial Coll London, London, England
[22] Chelsea & Westminster Hosp, London, England
[23] Rhein Freidrich Wilhelms Univ Bonn, Dept Palliat Med, D-53113 Bonn, Germany
[24] MC Mutual, Dept Neurol, Barcelona, Spain
[25] Neurosci Technol, Barcelona, Spain
[26] Neurosci Technol, London, England
[27] Tech Univ Munich, Dept Neurol, D-80290 Munich, Germany
[28] Heidelberg Univ, Ctr Biomed & Med Technol Mannheim, Chair Neurophysiol, Heidelberg, Germany
[29] S Anna Univ Hosp Ferrara, Dept Neurosci & Rehabil, Ferrara, Italy
[30] Univ Minnesota, Minneapolis, MN USA
[31] Univ Calif San Diego, Dept Anesthesiol, La Jolla, CA 92093 USA
[32] McGill Univ, Dept Family Med, Montreal, PQ H3A 2T5, Canada
[33] McGill Univ, Dept Anaesthesia, Montreal, PQ H3A 2T5, Canada
[34] Rambam Hlth Care Campus, Dept Neurol, Haifa, Israel
[35] Univ Dusseldorf, German Diabet Ctr, Inst Clin Diabetol, D-40225 Dusseldorf, Germany
[36] Univ Hosp, Leibniz Ctr Diabet Res, Dusseldorf, Germany
[37] Univ Hosp, Dept Metab Dis, Dusseldorf, Germany
关键词
Chronic pain; Neuropathic pain; Quantitative sensory testing; Recommendations; Sensory neuropathies; VIBRATION PERCEPTION THRESHOLD; SMALL FIBER NEUROPATHY; ALPHA-LIPOIC ACID; DIABETIC POLYNEUROPATHY; THERMAL THRESHOLDS; SOMATOSENSORY PERCEPTION; PERIPHERAL NEUROPATHY; CUTANEOUS SENSATION; NERVE-CONDUCTION; EFNS GUIDELINES;
D O I
10.1016/j.pain.2013.05.047
中图分类号
R614 [麻醉学];
学科分类号
100217 [麻醉学];
摘要
Quantitative sensory testing (QST) is a psychophysical method used to quantify somatosensory function in response to controlled stimuli in healthy subjects and patients. Although QST shares similarities with the quantitative assessment of hearing or vision, which is extensively used in clinical practice and research, it has not gained a large acceptance among clinicians for many reasons, and in significant part because of the lack of information about standards for performing QST, its potential utility, and interpretation of results. consensus meeting was convened by the Neuropathic Pain Special Interest Group of the International Association for the Study of Pain (NeuPSIG) to formulate recommendations for conducting QST in clinical practice and research. Research studies have confirmed the utility of QST for the assessment and monitoring of somatosensory deficits, particularly in diabetic and small fiber neuropathies; the assessment of evoked pains (mechanical and thermal allodynia or hyperalgesia); and the diagnosis of sensory neuropathies. Promising applications include the assessment of evoked pains in large-scale clinical trials and the study of conditioned pain modulation. In clinical practice, we recommend the use QST for screening for small and large fiber neuropathies; monitoring of somatosensory deficits; and monitoring of evoked pains, allodynia, and hyperalgesia. QST is not recommended as a stand-alone test for the diagnosis of neuropathic pain. For the conduct of QST in healthy subjects and in patients, we recommend use of predefined standardized stimuli and instructions, validated algorithms of testing, and reference values corrected for anatomical site, age, and gender. Interpretation of results should always take into account the clinical context, and patients with language and cognitive difficulties, anxiety, or litigation should not be considered eligible for QST. When appropriate standards, as discussed here, are applied, QST can provide important and unique information about the functional status of somatosensory system, which would be complementary to already existing clinical methods. (c) 2013 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:1807 / 1819
页数:13
相关论文
共 123 条
[1]
Neurophysiological characterization of posthemiotomy pain [J].
Aasvang, Eske Kvanner ;
Brandsborg, Birgitte ;
Christensen, Bente ;
Jensen, Troels Staehelin ;
Kehlet, Henrik .
PAIN, 2008, 137 (01) :173-181
[2]
Habituation and short-term repeatability of thermal testing in healthy human subjects and patients with chronic non-neuropathic pain [J].
Agostinho, Claudia Maria Santos ;
Scherens, Andrea ;
Richter, Helmut ;
Schaub, Claudia ;
Rolke, Roman ;
Treede, Rolf-Detlef ;
Maier, Christoph .
EUROPEAN JOURNAL OF PAIN, 2009, 13 (08) :779-785
[3]
Technology literature review: Quantitative sensory testing [J].
Chong P.S.T. ;
Cros D.P. .
MUSCLE & NERVE, 2004, 29 (05) :734-747
[4]
The sensory symptoms of diabetic polyneuropathy are improved with α-lipoic acid -: The SYDNEY trial [J].
Ametov, AS ;
Barinov, A ;
Dyck, PJ ;
Hermann, R ;
Kozlova, N ;
Litchy, WJ ;
Low, PA ;
Nehrdich, D ;
Novosadova, M ;
O'Brien, PC ;
Reljanovic, M ;
Samigullin, R ;
Schuette, K ;
Strokov, I ;
Tritschler, H ;
Wessel, K ;
Yakhno, N ;
Ziegler, D .
DIABETES CARE, 2003, 26 (03) :770-776
[6]
Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy - A randomized controled trial [J].
Apfel, SC ;
Schwartz, S ;
Adornato, BT ;
Freeman, R ;
Biton, V ;
Rendell, M ;
Vinik, A ;
Giuliani, M ;
Stevens, JC ;
Barbano, R ;
Dyck, PJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (17) :2215-2221
[7]
Experimental and Clinical Applications of Quantitative Sensory Testing Applied to Skin, Muscles and Viscera [J].
Arendt-Nielsen, Lars ;
Yarnitsky, David .
JOURNAL OF PAIN, 2009, 10 (06) :556-572
[8]
AREZZO JC, 1993, NEUROLOGY, V43, P1050
[9]
Neuropathic pain: Are there distinct subtypes depending on the aetiology or anatomical lesion? [J].
Attal, N. ;
Fermanian, C. ;
Fermanian, J. ;
Lanteri-Minet, M. ;
Alchaar, H. ;
Bouhassira, D. .
PAIN, 2008, 138 (02) :343-353
[10]
Thermal hyperalgesia as a marker of oxaliplatin neurotoxicity: A prospective quantified sensory assessment study [J].
Attal, N. ;
Bouhassira, D. ;
Gautron, M. ;
Vaillant, J. N. ;
Mitry, E. ;
Lepere, C. ;
Rougier, P. ;
Guirimand, F. .
PAIN, 2009, 144 (03) :245-252